Lazard Asset Management
OYST

Lazard Asset Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Lazard Asset Management’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,545
Closed -$82K – 2602
2021
Q4 		$82K Buy
+4,545
New +$57.7K ﹤0.01% 1521

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lazard Asset Management's OYST Position: Q1 2022 in Review

Lazard Asset Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2022, closing a stake of 4,545 shares — an estimated $82K sold.

Lazard Asset Management first reported a position in OYST in Q4 2021 and held it in 1 quarter. The position peaked at $82K in Q4 2021. 72 funds tracked by Wall St. Rank hold OYST as of Q1 2022.

  • Lazard Asset Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Lazard Asset Management sold 4,545 Oyster Point Pharma, Inc. Common Stock shares in Q1 2022, an estimated $82K.
  • Lazard Asset Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Lazard Asset Management's Oyster Point Pharma, Inc. Common Stock position peaked at $82K in Q4 2021.
  • 72 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2022.

Based on Lazard Asset Management's 13F filing for Q1 2022, filed 13 May 2022.